- $940.35m
- $3.49bn
- $2.73bn
Brief: QuidelOrtho Q2 EPS USD -0.8
QuidelOrtho Corp expected to post earnings of 28 cents a share - Earnings Preview
Brief: QuidelOrtho Q1 revenue USD 846.1 million
Brief: QuidelOrtho Reports First Quarter 2023 Financial Results
QuidelOrtho Corp reports results for the quarter ended in March - Earnings Summary
QuidelOrtho Corp expected to post earnings of $1.49 a share - Earnings Preview
QuidelOrtho rises on strong Q1 revenue forecast
Brief: QuidelOrtho Reports Preliminary Revenue Results For The First Quarter 2023
Brief: QuidelOrtho Receives De Novo FDA Authorization For Sofia 2 SARS Antigen+ FIA
Brief: QuidelOrtho Reports Q4 Revenue USD 866.5 Million
Brief: Quidelortho Reports Fourth Quarter Results
Quidelortho Corp reports results for the quarter ended in December - Earnings Summary
Quidelortho Corp expected to post earnings of $1.43 a share - Earnings Preview
Brief: Quidelortho Reports Preliminary Revenue Results For Fourth Quarter And Full Year 2022
Brief: Health Canada Grants License For Quidel® Triagetrue® High-Sensitivity Troponin I Test To Aid In The Diagnosis Of Myocardial Infarction
Brief: Quidelortho And Runda Medical Form Joint Venture To Develop And Manufacture Assays For Vitros® Platform
Brief: Quidelortho Announces Separation Of Chairman And Chief Executive Officer Roles
U.S. RESEARCH ROUNDUP- Autozone, Nike, Sachem Capital
Brief: Quidelortho Reports Third Quarter 2022 Financial Results